obert T. Schooley, M.D. is the Division Head and Professor of Medicine in the Department of Medicine, Division of Infectious Diseases, at the University of California, San Diego (UCSD). Dr. Schooley received his medical degree from the Johns Hopkins University School of Medicine in 1974 and completed his medical house staff training at the Johns Hopkins Hospital in 1976. He completed fellowships in infectious diseases at the National Institute of Allergy and Infectious Diseases and at the Massachusetts General Hospital before joining the faculty of Harvard Medical School in 1981.
He led the NIAID’s AIDS Clinical Trials Group (ACTG) from 1995 to 2002. During his tenure as Group Chair the ACTG expanded to include research sites in Latin America, the Caribbean, South Asia and
Africa and is now the largest and most productive multinational clinical and translational research organization focusing on the pathogenesis and therapy of HIV and its complications.
He recently served a Member of the US Department of State’s PEPFAR (President’s Emergency Plan for AIDS Relief) Scientific Advisory Committee and as Chair of the NIH Drug Discovery and Resistance Study Section.
He was recruited to the University of California, San Diego in 2005 where he now serves as Head of the Division of Infectious Diseases. His current research interests include HIV and HCV pathogenesis and therapy and infections that cause morbidity and mortality in resource limited settings.
Dr. Robert T. Schooley is a renowned infectious diseases expert and Division Head at UCSD. With expertise in HIV/AIDS research, he has contributed significantly to clinical trials and global health initiatives. Dr. Schooley's current research focuses on HIV and HCV pathogenesis and therapy in resource-limited settings.